Laboratorios Farmaceuticos Rovi, S.A.
LABFF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $4,485,907 | $2,502,386 | $2,551,520 | $3,349,657 |
| - Cash | $27,186 | $25,322 | $124,945 | $99,035 |
| + Debt | $114,410 | $65,427 | $72,138 | $73,145 |
| Enterprise Value | $4,573,131 | $2,542,491 | $2,498,713 | $3,323,767 |
| Revenue | $763,749 | $829,509 | $817,698 | $648,677 |
| % Growth | -7.9% | 1.4% | 26.1% | – |
| Gross Profit | $467,710 | $483,344 | $512,429 | $379,835 |
| % Margin | 61.2% | 58.3% | 62.7% | 58.6% |
| EBITDA | $199,615 | $238,017 | $271,330 | $196,562 |
| % Margin | 26.1% | 28.7% | 33.2% | 30.3% |
| Net Income | $136,881 | $170,335 | $199,669 | $153,077 |
| % Margin | 17.9% | 20.5% | 24.4% | 23.6% |
| EPS Diluted | 2.67 | 3.2 | 3.73 | 2.76 |
| % Growth | -16.6% | -14.2% | 35.1% | – |
| Operating Cash Flow | $138,278 | $113,247 | $237,602 | $149,441 |
| Capital Expenditures | -$62,219 | -$55,187 | -$51,388 | -$40,940 |
| Free Cash Flow | $76,059 | $58,060 | $186,214 | $108,501 |